Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
This study aims to investigate the prevalence of ADHD and other psychopathology, and current function and life quality among several high risk populations of imprisoned adults and adolescents who receive special resources in school or dropout from school.
Attention-deficit/hyperactivity disorder (ADHD) is a common (5-10%) childhood-onset
neuropsychiatric disorder worldwide among children and adolescents with 50- 60% persistence
to adulthood (3-4%). Individuals with ADHD have been reported to have higher risk of school
failure, conduct problems, antisocial behaviors, legal problems, substance use problems and
other psychiatric comorbidities, and face many difficulties of the interpersonal
relationship, occupation and family in every day life. Despite plenty of researches reported
in the west countries, we have limited information in Taiwan about adult ADHD and the
associated impact on the function and quality of life of the affected individuals. For the
perspective of public health, it's mandatory to collect information from the high risk
populations of ADHD for further policy establishment to prevent further impact on
individuals, families, and society in Taiwan.
This study target on two populations: (1) imprisoned adults (2) adolescents with problems in
school and followed by three private charitable organizations. Each population is assessed
by the instruments for ADHD symptoms (ASRS and SNAP-IV), psychopathology (ASRI and/or YSR
and CBCL), and academic/social/occupational /family function (WFIRS-S, WFIRS-P). Adult
population is also checked for the quality of life (AAQoL). We will recruit the
community-based controls matching with sex and age is assessed with the same instruments.
We anticipate that this study will provide the primitive data on the prevalence of ADHD and
other psychopathology, academic/occupational/social/family function, quality of life of
adolescent and adult patients in the high risk populations, will evaluate the difference
between adults in prison, adolescents dropping out from school, and their community controls
with regards to symptomatology, quality of life, and function; and young psychiatric
researchers will learn to collect data, conduct statistical analysis, and prepare the
manuscript. Our findings should have clinical implication in assessing adults and
adolescents at high risk of ADHD and provide the reference data for future public health
policy planning regarding early identification of ADHD at childhood and intervention program
to offset the adverse social and academic/occupational sequalae of ADHD.
;
Observational Model: Case Control
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |